Technical Analysis for CHMA - Chiasma, Inc.

Grade Last Price % Change Price Change
F 3.89 1.04% 0.04
CHMA closed up 1.04 percent on Friday, February 26, 2021, on approximately normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
Earnings due: Mar 15
*** please verify all earnings dates ***

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical CHMA trend table...

Date Alert Name Type % Chg
Hammer Candlestick Bullish 0.00%
Stochastic Buy Signal Bullish 0.00%
Lizard Bullish Bullish Day Trade Setup 0.00%
Doji - Bullish? Reversal 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Oversold Stochastic Weakness 1.04%
Oversold Stochastic Weakness -1.77%
MACD Bearish Centerline Cross Bearish -0.51%
Stochastic Reached Oversold Weakness -0.51%
Older End-of-Day Signals for CHMA ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Lower Bollinger Band Support 1 day ago
Down 3% 1 day ago
1.5x Volume Pace 1 day ago
Down 2 % 1 day ago
Down 1% 1 day ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Chiasma, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing oral forms of therapies for patients suffering from orphan diseases. Its product candidate is oral octreotide, which have completed a multinational Phase 3 clinical trial for the treatment of acromegaly, a condition that results in the body's production of excess growth hormone. Chiasma, Inc. was founded in 2001 and is headquartered in Newton, Massachusetts.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Industry Organ Systems Medication Endocrine System Hormones Orphan Disease Orphan Diseases Growth Hormone Late Stage Biopharmaceutical Acromegaly Neuroendocrinology

Is CHMA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 7.75
52 Week Low 2.88
Average Volume 1,322,868
200-Day Moving Average 4.72
50-Day Moving Average 4.24
20-Day Moving Average 4.19
10-Day Moving Average 4.10
Average True Range 0.23
ADX 19.63
+DI 15.85
-DI 26.14
Chandelier Exit (Long, 3 ATRs ) 4.30
Chandelier Exit (Short, 3 ATRs ) 4.38
Upper Bollinger Band 4.70
Lower Bollinger Band 3.68
Percent B (%b) 0.2
BandWidth 24.33
MACD Line -0.08
MACD Signal Line -0.02
MACD Histogram -0.054
Fundamentals Value
Market Cap 224.86 Million
Num Shares 57.8 Million
EPS -1.23
Price-to-Earnings (P/E) Ratio -3.17
Price-to-Sales 1401.28
Price-to-Book 2.22
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.27
Resistance 3 (R3) 4.24 4.08 4.20
Resistance 2 (R2) 4.08 3.99 4.10 4.18
Resistance 1 (R1) 3.99 3.93 3.91 4.02 4.16
Pivot Point 3.83 3.83 3.80 3.85 3.83
Support 1 (S1) 3.74 3.74 3.66 3.77 3.62
Support 2 (S2) 3.58 3.68 3.60 3.60
Support 3 (S3) 3.49 3.58 3.58
Support 4 (S4) 3.52